Clinical Trial Update: Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 mass balance and metabolic profiling study of [14C]AZD5672 in healthy male volunteers, outlining pharmacokinetic and metabolic data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD5672 (AZD5672)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED